{"id":"W3007674754","doi":"10.1038/s41589-020-0484-2","title":"A drug discovery platform to identify compounds that inhibit EGFR triple mutants","year":2020,"lang":"en","type":"article","venue":"Nature Chemical Biology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Ontario Institute for Cancer Research; University of Toronto; University Health Network; SickKids Foundation; Princess Margaret Cancer Centre; Public Health Ontario; Hospital for Sick Children","funders":"National Institute of General Medical Sciences; Technische Universität Dresden; Government of Ontario; National Institutes of Health; Ontario Genomics; Canadian Cancer Society Research Institute; Québec Consortium for Drug Discovery; Genome Canada; Cancer Research Society; Fondation Brain Canada; National Cancer Institute; Yale University","keywords":"Receptor tyrosine kinase; Drug discovery; Epidermal growth factor receptor; Tyrosine kinase; Biology; Mutant; Transmembrane protein; In vitro; High-throughput screening; Computational biology; Receptor; Pharmacology; Cell biology; Cancer research; Biochemistry; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003149441,0.0009047454,0.0006878442,0.0008278251,0.0003744139,0.00101352,0.0006491471,0.0008426845,0.005228199],"category_scores_gemma":[0.0002595066,0.0005030432,0.0006418882,0.0003305798,0.0001940728,0.0005291405,0.0008428242,0.001361278,0.002565735],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004474121,"about_ca_system_score_gemma":0.0005860737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004524946,"about_ca_topic_score_gemma":0.0009724263,"domain_scores_codex":[0.999772,0.00001542642,0.000007940371,0.00005002844,0.000110196,0.0000442875],"domain_scores_gemma":[0.9998926,0.00001942318,0.00001889329,0.00001156989,0.00001804953,0.00003940761],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005295131,0.0003125791,0.0003713568,0.0001138765,0.0000714201,0.0002295049,0.00001844211,0.001510169,0.9432042,0.002043181,0.007837517,0.04375827],"study_design_scores_gemma":[0.0005921353,0.002088674,0.0017887,0.00003462197,0.0002061259,0.0007152618,0.00002173311,0.03330674,0.9069579,0.002255168,0.05196357,0.00006933715],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7133712,0.008773251,0.1856329,0.005171543,0.001458344,0.002299172,0.01839975,0.01917912,0.04571474],"genre_scores_gemma":[0.7838781,0.006541749,0.1431807,0.001834951,0.0002815685,0.001387934,0.01634723,0.0005150106,0.04603272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005228199,"threshold_uncertainty_score":0.01749003,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03983932783787501,"score_gpt":0.3622726590527093,"score_spread":0.3224333312148343,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}